Stocks-SURF-Surface Oncology Inc

SURF Surface Oncology Inc

0.9798 0.0598 (6.50%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest
-2.04% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
59.32M
Day’s Range
0.8900
-
0.9600
52W Range
0.5820
-
4.04
Volume (3M)
317.91K
Price-Earnings Ratio
9.42
Revenue
30.16M

Surface Oncology Inc Latest News

View All
Pinned Post
eToro Team
🎉 Here’s a little preview introducing 16 YEARS of INVESTING on eToro 😏🤑 With love, - The eToro Team youtu.be/UFYvpJxh2qA
Like CommentShare
Show more comments2 of 49
1 reply
1 reply
null
.
Top Discussions
LordKingDayo
Spoke about 19 stocks in the ARKInvest $ARKG #Genomics ETF FUND... and I shared the best 4 to buy atm. I also spoke about $BNGO (BioNano Genomics Inc) at the end. $RXRX $QSI $CDXS (Codexis Inc) $REGN (Regeneron Pharmaceuticals) $BFLY (Butterfly Network Inc.) $NRIX $PRME $PFE (Pfizer) $GH (Guardant... Show More
Kingandrewss
$SURF (Surface Oncology Inc) Within the next 4 Hours I am predicting - $ 1.0000
Yes I am Bullish 🟢
100.00%
No I am Bearish 🛑
100.00%
Like CommentShare
null
.
arek121281
$SURF (Surface Oncology Inc) in 9/29/2021 surface had about Issued 45,503 000 shares. Now it has 60,542 000. I haven't seen any information that $SURF planned issue new shares? Someone knew something more than I?
Henrik Bilevits
Edited
𝗣𝗘𝗥𝗙𝗢𝗥𝗠𝗔𝗡𝗖𝗘 𝗡𝗢𝗩𝗘𝗠𝗕𝗘𝗥 𝟮𝟬𝟮𝟮 November month did not disappoint, we had a bit of a Santa Claus rally. 𝗠𝘆 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 November: +7.82% YTD: -11.99 𝗠𝘆 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝗰𝗼𝗺𝗽𝗮𝗿𝗲𝗱 𝘁𝗼: ✅ SPX500 November: +5.38% ✅ SPX500 YTD: -14.39 ✅ NSDQ100 November: +5.48 ✅ NSDQ100... Show More
MarketUpdates
Edited
$SURF (Surface Oncology Inc) Q4 2022 earnings report is expected to be released
1
MAR
REPORTS
Surface Oncology Inc Q4 2022 earnings report is expected to be released before market open
Notify me
SURF
SURF
Surface Oncology Inc
0.9798
0.0598
(6.50%)
Trade
SURF
Surface Oncology Inc
0.9600
0.0598 (6.50%)
Trade
Like CommentShare
2 replies
null
.

About Surface Oncology Inc

Surface Oncology is a healthcare company headquartered in Cambridge, Massachusetts and working on a local basis only. Founded in 2014, the company is listed under the ticker SURF on the NASDAQ GM. Its area of specialisation is immuno-oncology. Keep up to date with SURF stock news and updates with eToro.
67
Employees
Cambridge, Massachusetts, US
HQ
2014
Founded
Robert W. Ross, MD
CEO
Show More

Upcoming Earnings

1
MAR
REPORTS
Surface Oncology Inc Q4 2022 earnings report is expected to be released before market open

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
36
Very Low
Industry 
Avg. 45 
32
Environment
35
Social
38
Governance

People Also Bought